Scientists Use 'Dancing Molecules' to Heal Lab-Grown Spines

Researchers developed an injectable therapy that encouraged neurite and neuron growth in damaged spinal organoids.

Published on Feb. 25, 2026

Got story updates? Submit your updates here. ›

Scientists at Northwestern University have created spinal organoids with common spinal injuries and used an innovative 'dancing molecules' therapy to promote the regeneration of neurites and neurons in the damaged tissue. The therapy, which involves fine-tuning the motion of molecules to better interact with cellular receptors, has previously shown promise in animal models and is now being validated through this organoid research as a potential treatment for human spinal cord injuries.

Why it matters

Spinal cord injuries can have devastating impacts on quality of life, so finding effective therapies is a major priority for medical researchers. Organoids provide an affordable and ethical way to test potential treatments before moving to human clinical trials. This study demonstrates the promise of the 'dancing molecules' approach in addressing key aspects of spinal cord damage, like neurite and neuron regeneration.

The details

The researchers grew spinal organoids with two common types of spinal injuries - lacerations and compressive contusions. When they applied the 'dancing molecules' therapy via injection, it formed a scaffold that reduced inflammation and glial scarring. Notably, the treatment also encouraged the regrowth of neurites, which are crucial connections between neurons that are often severed in spinal injuries. The researchers observed the organized growth of new neurons as well, a key step toward restoring function.

  • The 'dancing molecules' therapy was first described in a 2021 study led by Northwestern's Samuel Stupp.
  • This new organoid research was published in February 2026.

The players

Samuel Stupp

A lead author on the new spinal organoid study and the researcher who first described the 'dancing molecules' therapy in 2021.

Northwestern University

The institution where the spinal organoid research was conducted.

Got photos? Submit your photos here. ›

What they’re saying

“Receptors in neurons and other cells constantly move around. By making the molecules move, 'dance,' or even leap temporarily out of these structures, known as supramolecular polymers, they are able to connect more effectively with receptors.”

— Samuel Stupp (Popular Mechanics)

“One of the most exciting aspects of organoids is that we can use them to test new therapies in human tissue. Short of a clinical trial, it's the only way you can achieve this objective...This is validation that our therapy has a good chance of working in humans.”

— Samuel Stupp (Press Statement)

What’s next

Future research will focus on developing even more realistic spinal organoids before ultimately testing the 'dancing molecules' therapy in human clinical trials.

The takeaway

This organoid research represents an important step toward finding effective treatments for spinal cord injuries, leveraging an innovative 'dancing molecules' approach that has shown promise in animal models and is now being validated in human-derived tissue.